← News

HEALTH

144 stories

  1. A hand holding a phone showing Empatica's WellPD app daily summary next to the WellPD wrist-worn sensorHEALTHEmpatica's WellPD puts an FDA-cleared Parkinson's tracker on the wrist, for home useEmpatica launched WellPD on Wednesday, Oct. 28, 2026, an FDA-cleared and CE-marked wrist-worn device and companion app that lets people with Parkinson's monitor their symptoms at home.
  2. Formation Bio cofounder and CEO Ben LiuHEALTHFormation Bio raises a $600 million fund to buy the drugs other companies gave up onFormation Bio said Wednesday, Oct. 28, 2026, that it has $600 million in commitments for its new Drug Development Accelerator Fund, which will acquire clinical-stage drug programs and push them through key trials using the company's AI development platform.
  3. Anthropic chart of Mithril Medicine's LAMA2-CMD mouse results: grip strength and triceps muscle force for untreated, treated and healthy mice, captioned "Treated mice were about twice as strong"HEALTHAnthropic bought a one-person biotech that used Claude to get a muscular dystrophy drug to mouse results in 18 monthsAnthropic said Tuesday, Oct. 27, 2026, that it acquired Mithril Medicine, a one-person company developing treatments for rare childhood muscular dystrophies, and published early results from six drug-development partnerships that use Claude.
  4. Vera Health co-founders Maxime Allouch and Taieb Bennani seated in leather armchairs in front of a brick wall, in an official Vera Health photoHEALTHVera Health raises $28.5 million after its clinical AI search spread to 800,000 clinicians by word of mouthVera Health, a clinical AI search engine that grades the evidence behind every answer, said Tuesday, Oct. 27, 2026, it raised a $28.5 million Series A led by Threshold Ventures, bringing total funding to $32 million.
  5. Johns Hopkins Medicine Bayview Campus sign in front of Johns Hopkins Bayview Medical Center buildings in BaltimoreHEALTHA Johns Hopkins Bayview worker uploaded 3,182 patients' records to a public AI tool the hospital never approvedJohns Hopkins Bayview Medical Center in Baltimore is notifying 3,182 patients that their health information was exposed after a staff member uploaded a spreadsheet of patient data to a public AI tool the hospital had not approved for that use.
  6. Baidu Health's Oct. 24 launch event in China, with a presenter onstage in front of a giant screen introducing the Health Camera video-symptom featureHEALTHBaidu's new Health Camera lets you film your symptoms, and puts 150,000 real doctors behind the AIBaidu Health on Oct. 24, 2026 upgraded its Wenxin (ERNIE) health assistant with a "Health Camera" that lets users shoot and upload video of a symptom while describing it, plus a "Good Doctor matrix" that hands AI consultations to more than 150,000 real doctors from China's top-tier (grade-3A) hospitals.
  7. Pathos AI CEO Iker Huerga, black-and-white portraitHEALTHBristol Myers Squibb just led a $237 million bet on Pathos, the AI drug developerPathos AI said on Friday, Oct. 23, 2026, that it raised $237 million in a Series E led by Bristol Myers Squibb at an approximately $3 billion post-money valuation, to scale its agentic AI drug development platform and push its cancer pipeline toward late-stage trials.
  8. Coreline Soft AVIEW Aorta Metrics software screen showing a segmented 3D aorta, a straightened CPR view and an aorta dimension table by zoneHEALTHFDA cleared Coreline Soft's AI that measures the aorta from a routine chest CTCoreline Soft said on Friday, Oct. 23, 2026, that the FDA cleared AVIEW Aorta Metrics, AI software that automatically segments the aorta on chest CT and measures its diameter zone by zone.
  9. Microsoft AI CEO Mustafa Suleyman speaking on stage at a Microsoft event in April 2025HEALTHMicrosoft's AI "doctor panel" beat physicians on hard diagnoses, and now it's in ScienceMicrosoft AI said on Thursday, Oct. 22, 2026, that peer-reviewed results for its MAI-DxO diagnostic orchestrator were published in Science, showing it outperformed generalist physicians on complex and emergency-department cases at lower cost.
  10. Warp Sciences co-founders Kevin Weil, Sol Reisberg and DJ Patil, left to right, standing in a courtyardHEALTHOpenAI's former science chief raised $215 million to bring drug-research chemistry back from China, with robotsWarp Sciences came out of stealth on Thursday, Oct. 22, 2026, with $215 million led by Lightspeed Venture Partners to build U.S.-based chemistry services for drug research, combining human chemists, AI and lab robotics, with former OpenAI executive Kevin Weil as CEO.
  11. RIVANNA's Accuro XV ultrasound system, its screen showing a wrist scan with color-coded bone overlays beside a 3D view of the hand and forearmHEALTHThe FDA cleared an AI that color-codes bones on 3D ultrasound, the first step toward spotting fractures without an X-rayRIVANNA said on Thursday, Oct. 22, 2026, that the FDA has granted 510(k) clearance for BoneEnhance, a machine-learning module for its Accuro XV ultrasound system that segments bone and surrounding tissue and shows skeletal anatomy in 3D during image review.
  12. A clinician holds the Eko CORE 300 stethoscope chestpiece against a patient's chest, its round display showing a heart rate of 85HEALTHEko's new $199 stethoscope works the old-fashioned way, until you twist it and AI starts listening for murmursEko Health said on Thursday, Oct. 22, 2026, that the FDA has cleared its CORE 300, a stethoscope that switches between traditional and digital listening with a twist of the chestpiece and connects to Eko's FDA-cleared AI for structural heart-murmur detection, and that it is on sale now in the U.S.
  13. A terminal running Hugging Face's Carbon-X model locally, answering "What does this sequence encode?" by translating a DNA sequence into a peptideHEALTHHugging Face's Carbon-X lets you ask a DNA sequence questions in plain English, and it runs on a laptopHugging Face on Thursday, Oct. 22, 2026, released Carbon-X, an open-source model that reads both DNA and natural language, so researchers can ask what a sequence does or whether a mutation is likely harmful and get a conversational answer, running locally on their own hardware.
  14. HEALTHOpenAI set 1,946 AI agents loose on a mouse-brain gene atlas and got months of analysis in 32 minutes, plus a few leads worth testingOpenAI, PerturbAI and Scripps Research said on Wednesday, Oct. 21, 2026, that 1,946 AI agents running OpenAI's life-sciences model GPT-Rosalind in parallel, one per gene disruption, analyzed an existing whole-brain CRISPR dataset from millions of mouse brain cells in 32 minutes and produced testable research leads.
  15. HEALTHElucid's FDA-cleared AI estimates whether a clogged heart artery is starving blood flow, and it counts the plaque, not just the narrowingElucid, a Boston medical-imaging software company, said on Wednesday, Oct. 21, 2026, that the FDA has cleared FFR-IQ, AI software that estimates fractional flow reserve, a measure of whether a narrowed coronary artery is limiting blood flow, from a coronary CT angiography scan, and that the product is now commercially available.
  16. HEALTHEpic will let its hospital AI agents reach into other apps, from ambulance trackers to the cafeteriaEpic, the electronic health record giant, said on Wednesday, Oct. 21, 2026, that app developers can now build "Connectors" that link their software to Epic's AI agents, so the agents can pull in outside information or complete tasks in other apps, such as ordering a hospitalized patient's meal.
  17. HEALTHAnthropic says Claude designed 17 lab-confirmed proteins that grab scorpion neurotoxins, but nobody has shown they stop a sting yetAnthropic said on Tuesday, Oct. 20, 2026, that an internal Claude research model, working inside Claude Science, designed small "minibinder" proteins against five scorpion neurotoxins, and that 17 of the 211 designs tested by two outside labs met its criteria for binding a toxin dangerous to humans.
  18. HEALTHOpenAI buys Orchestra Bio to put AI agents in charge of the drug-development paperwork that slows new medicinesOpenAI said on Tuesday, Oct. 20, 2026, that it has acquired Orchestra Bio, a startup whose platform lets biotech and pharma teams hand the monitoring and coordination of drug programs to AI agents, and that Orchestra's team and technology will join Rosalind, OpenAI's set of AI models and tools for life-sciences research.
  19. HEALTHAstraZeneca and Oracle want AI to find the patients drug trials can't, starting with blood pressure in Abu DhabiAstraZeneca and Oracle Health and Life Sciences said on Tuesday, Oct. 20, 2026, that they will test using AI and de-identified real-world patient data to speed up clinical-trial recruitment, spot drug-safety problems and get patients diagnosed sooner, starting with a program for uncontrolled high blood pressure in Abu Dhabi with local health company M42.
  20. HEALTHEli Lilly signs a deal worth up to $1.1 billion with a Chinese AI drug-delivery companyMetis TechBio said on Monday, Oct. 19, 2026, that it has entered a strategic collaboration with Eli Lilly to discover new lipid nanoparticle (LNP) delivery systems designed to send therapies to specific tissues, using its AI-driven AiLNP platform, in a deal worth up to about $1.1 billion in milestones.
  21. A Masimo smartSET pulse-oximetry sensor wrapped around a patient's finger on a hospital bed, with a smartSET adhesive sensor shown in the lower leftHEALTHMasimo's hospital finger sensor can now flag possible AFib, after an FDA clearanceMasimo on Saturday, Oct. 17, 2026, said it received FDA 510(k) clearance for an atrial fibrillation detection feature on its Radius VSM wearable monitor, part of a pulse-oximetry platform it calls smartSET.
  22. Figure 1 from the Percival paper: Penn Medicine BioBank CT cohort pipeline and CT-report contrastive vision-language model diagramHEALTHPenn Medicine's Percival AI reads CT scans for diseases the scan wasn't ordered forPenn Medicine on Friday, Oct. 16, 2026, described Percival, a CT vision-language model that flags chronic disease traces and future risk beyond the reason a scan was ordered, based on a new study in npj Digital Medicine.
  23. SimBioSys TumorSight 3D model built from a breast MRI, showing a tumor with slow-growing and fast-growing regions and surrounding blood vesselsHEALTHFDA clears SimBioSys' AI tool that predicts breast cancer recurrence from an MRISimBioSys said on Thursday, Oct. 15, 2026, that the FDA granted 510(k) clearance to TumorSight Risk, which it calls the world's first AI-powered, MRI-derived prognostic tool for breast cancer recurrence risk, producing individualized five- and ten-year estimates from routine breast MRI, pathology and clinical data.
  24. insitro founder and CEO Daphne Koller speaking on stage in a dark jacketHEALTHAstraZeneca pays insitro up to $1.5 billion to find AI drug targets for liver and heart diseaseAstraZeneca and insitro on Thursday, Oct. 15, 2026, announced a worldwide exclusive AI drug-discovery collaboration for metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies, with insitro receiving $40 million upfront and eligibility for up to about $1.46 billion in milestones plus single-digit royalties.
  25. Suki founder and CEO Punit Soni, wearing a black turban and glasses, in his official company portrait against a yellow backgroundHEALTHSuki raises $90 million to turn its doctor's AI scribe into agents that run more of the hospitalSuki, which makes AI that listens to doctor-patient visits and writes up the notes, announced a $90 million Series E on Tuesday, Oct. 13, 2026, to push beyond documentation into clinical reasoning, billing and operations. New investors Healthier Capital, Crosslink Capital and Hercules Capital joined all of Suki's existing institutional backers, including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures and Zoom Ventures. Suki did not disclose a valuation.
  26. Scarlet co-founders James Dewar and Jamie Cox smiling outside a sandstone buildingHEALTHScarlet, the regulator-approved body that certifies AI medical devices, raises $50 million to expand into the US and AsiaScarlet, a government-designated certification body for AI and software medical devices, announced a $50 million Series B on Monday, Oct. 12, 2026, led by Headline with new investor Notion Capital and existing backers Atomico, Creandum, Kindred Capital and Entrepreneurs First. The company decides whether AI medical devices can go on sale in Europe and the UK, and says the money will fund expansion in the US and Asia-Pacific and more expert reviewers.
  27. Google's official Fitbit Edge launch graphic: five Fitbit Edge trackers in different finishes and bands, with the Google and Fitbit Edge wordmarksHEALTHGoogle's new $180 Fitbit Edge brings its AI health coach and 'check engine light' health trends to cheaper trackersGoogle announced the Fitbit Edge on Monday, Oct. 12, 2026, a $179.99 tracker that sits between the screenless Fitbit Air and the Pixel Watch 5. Alongside it, Google is bringing Health Guardian, its background tracking of blood pressure and insulin resistance trends, to Fitbit Air and Fitbit Edge for Google Health Premium subscribers later this month, with its AI Health Coach on hand to explain what the shifts might mean.
  28. HEALTHThe Lancet names malicious AI and nuclear war as the only two threats that could wipe out humanity by 2100The Lancet Commission on 21st Century Global Threats to Health, published Sunday, Oct. 11, 2026, and launched at the World Health Summit in Berlin, picked 17 threats that could cost humanity at least a billion years of healthy life by 2100. Only two were judged to carry a risk of extinction: the malicious use of artificial intelligence and nuclear conflict. Both are unlikely, the commission says, but acting on AI risk alone could avert an estimated 10.4 billion years of healthy life lost.
  29. HEALTHAI and health-tech companies have been lobbying Medicare officials in a 1,700-member Slack the government runsA KFF Health News investigation published Friday, Oct. 9, 2026, found that the Centers for Medicare & Medicaid Services has run a private Slack workspace since August 2025 where tech companies, investors and federal health officials discuss AI health apps, Medicare promotion and access to medical records. The workspace has about 1,700 members, few of them patient advocates or doctors. CMS says it is an open, voluntary technical collaboration; legal experts told KFF it looks like a federal advisory committee, which would have to meet in public.
  30. HEALTHGoogle's medical chatbot interviewed 98 real urgent-care patients, and doctors never had to step inGoogle and Beth Israel Deaconess Medical Center published a study in The Lancet on Thursday, Oct. 8, 2026, testing AMIE, Google's research diagnostic chatbot, with real patients. Ninety-eight adults chatted with AMIE before urgent primary-care visits while physicians watched every conversation live. None of the chats had to be stopped for safety, and most doctors who read AMIE's notes said they helped them prepare.
  31. HEALTHGSK tested Chai Discovery's AI-designed proteins in its own lab, found binders for every target, and signed onChai Discovery said on Friday, Oct. 9, 2026, that it has started a collaboration with GSK after the drugmaker ran Chai's AI-generated protein designs through its own wet-lab tests and found binders to every target it tested. The designs were made zero-shot, without training on the specific targets. GSK will now get access to Chai's platform, including its folding and design models, for discovery work across its pipeline. Financial terms were not disclosed.
  32. Illumina's SpliceAI2 launch graphic: a gold DNA helix on a pale orange fieldHEALTHIllumina's new SpliceAI2 finds 17% more disease-linked gene variants other splicing models missIllumina said on Thursday, Oct. 8, 2026, that it is releasing SpliceAI2, a new genomic AI model meant to catch disease-relevant splice variants that other tools miss. On a rare-disease research dataset, Illumina says SpliceAI2 identified 17% more disease-relevant variants than other splicing models, and that together with its PromoterAI and PrimateAI-3D models the suite can now flag up to twice as many variants with predicted biological impact.
  33. Diagram of Danaher's AI-powered autonomous lab: a four-step design-make-test-learn loop, plus targets of up to 8 times faster reagent discovery, up to 10 times more reagents a year, and scale in early 2027HEALTHDanaher is building an AI lab that designs, makes and tests antibodies with robots in the loopDanaher, the big maker of lab instruments and research tools, said on Wednesday, Oct. 7, 2026, that it plans to launch its first AI-powered autonomous lab. Based at its Abcam unit, the lab uses AI to design antibodies and other affinity reagents, then robots build and test each one and feed the results back into the model. Danaher says it should run at scale in early 2027.
  34. The Virtual Biology Initiative wordmark in green on a dark background, the official graphic Biohub released with its Oct. 7, 2026 announcementHEALTHThe US government, Google DeepMind and Meta put $1.8 billion behind Biohub's plan to build a "virtual cell"Biohub, the nonprofit research institute backed by Mark Zuckerberg and Priscilla Chan, said on Wednesday, Oct. 7, 2026, that it, the U.S. Department of Energy, the National Institutes of Health and a group of tech companies are committing $1.8 billion in money, data, computing and lab technology to generate open biological data for training AI models. The goal is software that can predict how a cell reacts to a drug or a change before anyone runs the experiment.
  35. Desk graphic: the UK government and MHRA accept all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, with AI medical devices monitored throughout their working life, draft guidance by December 2026, AI Airlock Phase 3 opening, and a full roadmap by spring 2027HEALTHUK accepts all 44 recommendations to overhaul how AI medical tools are regulatedOn Tuesday, Oct. 6, 2026, the UK government said it will accept in full all 44 recommendations from the National Commission into the Regulation of AI in Healthcare, a doctor-led panel. The medicines regulator, the MHRA, also opened applications for the third phase of AI Airlock, its testing program for AI medical devices.
  36. Nolla Health's launch graphic for its Utah pilot, reading The First AI-Powered Prescriptions, now piloting in Utah with Nolla DermHEALTHUtah lets an AI write acne prescriptions with no doctor signing off firstStarting Monday, Oct. 5, 2026, Utah residents 18 and older can get an acne prescription written by Nolla Health's AI after a face scan and a medical questionnaire, with no doctor approving it beforehand once the early phase ends. Bloomberg reports it is the first time a US state has let AI take over a doctor's role in prescribing.
  37. Abogen ABO2203 deal card — $575M upfront and up to $7.2B milestones with Novartis for mRNA-encoded T-cell engagerHEALTHAbogen licenses its mRNA T-cell engager to Novartis for $575M upfrontChina’s Abogen Biosciences said Friday it signed a licensing-and-option deal with Novartis for ABO2203, an mRNA-encoded CD19×CD3 T-cell engager aimed at autoimmune disease, with $575 million upfront and up to about $7.2 billion more in milestones if all options are exercised.
  38. Xaira X-Design Vega desk card — XA-1 7-week oncology lead and XA-4 hard GPCR antagonistHEALTHXaira shows X-Design AI making drug-ready antibodies in weeks — including one GPCR traditional methods missedXaira Therapeutics on Friday published results for X-Design, its generative AI for antibodies, showing it produced a progressable binder for lead oncology program XA-1 in seven weeks and unlocked XA-4, a hard GPCR target where conventional discovery had already failed.
  39. XtalPi logo on white panel — hair-loss drug program enters IND-enabling studiesHEALTHXtalPi moves its AI-designed hair-loss drug into IND-enabling studiesXtalPi on Friday said its proprietary hair-loss drug program has entered IND-enabling studies, building on two AI-developed scalp-care ingredients already commercialized under its Groland brand.
  40. Desk graphic — Milliman Contract Clarity for Healthcare AI contract analyticsHEALTHMilliman releases Contract Clarity for Healthcare, AI that benchmarks medical contractsMilliman said Friday it released Milliman Contract Clarity for Healthcare, a platform that uses generative AI and healthcare cost analytics to translate dense pharmacy and medical contracts into structured, benchmarked insight in minutes instead of weeks.
  41. Indigo and magenta launch graphic — UMI /sign real-time Deaf–hearing communication on Bittensor SN78HEALTHUMI launches /sign for real-time Deaf–hearing communication on BittensorUniversal Motion Intelligence said Friday it launched a Bittensor AI network for motion-to-meaning intelligence and introduced /sign, a real-time two-way communication app between Deaf and hearing people that uses a standard camera.
  42. Coral launch graphic — AKASA autonomous mid-cycle inpatient coding under 90 secondsHEALTHAKASA launches autonomous AI for inpatient coding and documentationAKASA said Friday it launched an autonomous AI platform for inpatient medical coding and clinical documentation integrity, expanding from AI prebill review into mid-cycle work that used to take human coders 30 to 60 minutes.
  43. DaltonTx Structural Clustering UI mapping a screening library by predicted structure with known binders and confirmed hitsHEALTHDaltonTx opens an AI antibody discovery layer on its drug-discovery decision engineLondon-based DaltonTx said it launched advanced antibody discovery capabilities inside the Dalton platform, tying AI design and structure tools to experimental feedback so teams can decide which antibodies to take forward.
  44. HealthEdge unified AI platform product graphic — AI core with BPaaS and EPaaS layers for health plansHEALTHHealthEdge launches a unified AI platform meant to guarantee financial outcomes for health plansHealthEdge said it introduced a newly unified AI-powered platform and portfolio for health plans, combining payer software with implementation and operational expertise after its merger with UST HealthProof, and embedding AI in claims, payments, care management, provider data, and risk adjustment workflows.
  45. Cradle AI protein-design UI — Round 3 anti-HER2 antibody generate-candidates workflowHEALTHHansa Biopharma partners with Cradle to design autoimmune drugs with AI protein engineeringHansa Biopharma and Cradle said Thursday that Hansa will use Cradle’s AI-driven protein design and engineering platform across its discovery pipeline to design and optimize novel immunomodulatory candidates for severe autoimmune disease.
  46. ARPA-H Delphi program social card — Developing self-monitoring ecosystems to know thyselfHEALTHARPA-H awards Delphi teams up to $117.4M for modular AI biosensor chipletsARPA-H said Thursday it awarded Delphi program teams to replace bulky single-purpose biosensors with tiny modular chiplets that report broader biological data for chronic conditions, with an agency commitment of up to $117.4 million over 4.5 years.
  47. Ptarmigan-1 web app landing page for screening compounds against protein targets without a 3D structureHEALTHTalus Bio opens Ptarmigan-1, a structure-free AI model for proteome-wide drug screensTalus Bioscience said Thursday it released Ptarmigan-1, an AI model that predicts small-molecule binding sites across the human proteome without modeling a 3D protein structure, and made access available through a public portal.
  48. Imagene AI OlPredict Lung Prediction Panel graphic listing NSCLC genomic alterations predicted from H&E slidesHEALTHCellCarta and Imagene AI expand AI biomarker and companion-diagnostic path for pharmaCellCarta and Imagene AI said Thursday they expanded their collaboration so biopharma sponsors can validate, deploy, and scale AI-powered biomarker and companion diagnostic programs from assay development through clinical trials and regulatory readiness.
  49. Legato Frames Aria AI hearing glasses three-quarter studio product shot; SpeechSense AI from $999HEALTHLegato puts AI hearing glasses on sale in the U.S. starting at $999Legato said Thursday Legato Frames are available in the United States starting at $999 online at legatohearing.com, with select eyecare providers coming soon — FDA-regulated over-the-counter hearing aids built into prescription-ready eyewear for adults with mild-to-moderate hearing loss.
  50. Parakeet Health brand graphic — Convert patient demand into booked appointments; $10M Series AHEALTHParakeet Health raises $10M Series A to book more care with patient-access AIParakeet Health said Thursday it closed an oversubscribed $10 million Series A led by Canvas Ventures, bringing total funding to $13 million for an AI platform that turns inbound calls, outreach, fax, and web scheduling into booked appointments.
  51. Desk graphic — Autonomize Context AI Context Graph and Enterprise Extensions layers for healthcare agentsHEALTHAutonomize ships Context AI so healthcare agents share one governed knowledge layerAutonomize said Thursday that Autonomize Context AI is generally available — a shared context foundation that turns clinical terminology, policies, and institutional rules into living, auditable intelligence healthcare AI agents can reuse across workflows.
  52. Desk graphic — Biotia $9M financing for BIOTIA-ID Urine Test and clinical metagenomics expansionHEALTHBiotia raises oversubscribed $9M to scale AI metagenomic infection testsBiotia said Thursday it closed an oversubscribed $9 million financing to scale clinical metagenomics diagnostics for recurrent infections, expand women’s health tests, and move into orthopedic infection diagnostics.
  53. Everlywell Clairity Breast consumer UI showing a 5-year breast cancer risk score of 1.2% AverageHEALTHEverlywell puts Clairity’s FDA-authorized AI breast-risk score online nationwideEverlywell said Thursday Clairity Breast is commercially available nationwide on its consumer platform, giving women with a qualifying recent screening mammogram access to the first FDA-authorized AI tool that estimates five-year breast cancer risk from that mammogram.
  54. Google DeepMind official SynthID Bio announcement graphic: Introducing SynthID Bio with protein structuresHEALTHGoogle DeepMind launches SynthID Bio to watermark AI-designed proteinsGoogle DeepMind said Wednesday it introduced SynthID Bio, a family of watermarking methods that embed a verifiable signature into AI-generated protein sequences and predicted 3D structures while preserving biological function in lab tests.
  55. ARPA-H SURPASS official social card: Simulation-augmented, real-time Platform Adaptive Seamless TrialsHEALTHHHS launches ARPA-H SURPASS to speed clinical trials with models and agentsThe Department of Health and Human Services, through ARPA-H, said Wednesday it launched SURPASS — Simulation-augmented, Real-time Platform Adaptive Seamless Trials — plus companion projects STACK, COMMONS, and CINCH to redesign how drugs and biologics are tested in the U.S.
  56. MD Clarity RevFind Agent dashboard showing payer underpayment variance charts and plain-English agent answersHEALTHMD Clarity expands RevFind with agentic AI for provider underpaymentsMD Clarity said Wednesday it launched a major expansion of RevFind’s agentic AI so provider organizations can automatically detect underpayments and denials, uncover root causes, and prioritize recovery opportunities from continuous audits of their revenue data.
  57. Topos Bio Fig. 1 PeptoneBench chart: Topos-2 leads BioEmu, AlphaFold2, Boltz-2 on ensemble agreementHEALTHTopos Bio ships Topos-2 and Topos-Bind for “undruggable” proteinsSan Francisco AI biotech Topos Bio said Wednesday it is releasing Topos-2, a next-generation model that generates protein shape ensembles across the order–disorder spectrum, and previewing Topos-Bind, which it calls the first generative model for disordered proteins bound to small molecules.
  58. Desk graphic — Welldoc AI-Powered Care Loop: patient day sensors to Simon closed-SLM agent to clinician care teamHEALTHWelldoc launches AI care loop that keeps clinicians in control between visitsWelldoc said Wednesday it launched a next-generation digital-first care loop that connects a patient’s daily health data directly to clinicians through clinically validated closed Small Language Models and an AI care agent named Simon.
  59. Minset mCoder product graphic — Clinical Note to Evidence Span to ICD-10 code autonomous medical codingHEALTHSavista and Minset hit up to 93% touchless medical coding with audited accuracySavista said Wednesday its coding-automation partnership with Minset has reached up to 93% fully touchless medical coding while sustaining 100% accuracy in the audits that validated the rollout.
  60. Clarest Path clinical UI — patient Donna Adams with Critical risk, concurrent opioid+benzo FDA Black Box warning, polypharmacy flags, and AI-assisted Medication Review overlayHEALTHClarest launches Clarest Path, AI medication-risk platform for health plansClarest Health said Wednesday it launched the next generation of Clarest Path, a medication-intelligence platform that uses a real-time machine-learning engine to flag medication risk earlier for health plans and at-risk providers.
  61. Ceribell System product diagram — EEG headband, neonatal headcap, pocket recorder with continuous-seizure alert, Clarity AI, and cloud portalHEALTHCeribell wins FDA clearance for quantitative EEG trending softwareCeribell said Wednesday the FDA cleared new software for the Ceribell System that turns hours of complex EEG into bedside trends so clinicians can spot meaningful brain-activity changes sooner.
  62. Elsevier ClinicalKey for Nursing AI release graphic — Master the moment; clinical skills grounded in evidence-based nursing practiceHEALTHElsevier launches ClinicalKey Nursing AI for bedside nursing questionsElsevier said Tuesday it globally launched ClinicalKey Nursing AI, a clinical AI tool built specifically for nurses that answers natural-language questions at the point of care with cited, evidence-based nursing content.
  63. Heidi II product UI — SOAP note, Ask Heidi panel, NEJM/Cochrane/Wiley/BMJ knowledge strip, EHR task actionsHEALTHHeidi launches Heidi II, an agentic layer that does clinical follow-up workHeidi Health said Tuesday it launched Heidi II, moving its clinical AI from visit notes into agentic workflows that can pre-chart rounds, chase pathology, fill referral forms, and run saved Routines while clinicians stay in control of what leaves the system.
  64. Tremont AI site hero: Foundation models for toxicologic pathology with dose-response chartHEALTHTremont AI emerges from stealth with multimodal models for preclinical drug safetyTremont AI, a Boston biomedical AI company focused on preclinical drug safety, said Tuesday it emerged from stealth with multimodal foundation models and AI agents built to help scientists analyze pathology and other evidence across preclinical safety studies.
  65. Kyunghyun Cho, co-founder and CEO of Ortet, at a conference (CC BY-SA 4.0)HEALTHOrtet launches as a frontier AI lab for health with $500M from ThoreauOrtet, a frontier artificial intelligence lab for health, said Tuesday it launched with a $500 million commitment from Thoreau to build compute, data infrastructure, research, and health-focused models that learn across biology, clinical care, operations, and finance around each patient.
  66. Desk graphic — AbbVie × Valkai clinical development AI partnership workflowHEALTHAbbVie partners with Valkai to put AI into clinical development workflowsAbbVie said Tuesday it is partnering with Valkai, a life-sciences AI platform, to deploy purpose-built AI across targeted areas of clinical research so teams can generate insights faster and look for chances to shorten development timelines.
  67. Tempus ECG-AI product workflow graphic — multimodal ECG inputs to AI patient identification, family that now includes FDA-cleared ECG-MRHEALTHFDA clears Tempus ECG-MR to flag undiagnosed mitral regurgitation on a standard ECGTempus AI on Monday said the FDA granted 510(k) clearance for Tempus ECG-MR, an AI product that analyzes a standard 12-lead resting ECG for signs linked to undiagnosed moderate or severe mitral regurgitation in older patients with heart risk factors.
  68. Labeled anatomical diagram of the human pancreas and nearby organsHEALTHMayo AI flags pancreatic cancer risk up to 3 years early25 Sep 2026 (ET): American College of Surgeons released findings from Mayo Clinic researchers: an AI model reading longitudinal records and routine labs predicted pancreatic-cancer risk up to three years before diagnosis. Results go to ACS Clinical Congress 2026; not yet peer reviewed.
  69. da Vinci Xi robotically-assisted surgical system patient-side cart with robotic armsHEALTHFDA posts draft guidance for robotically-assisted surgical devices25 Sep 2026 (ET): The FDA published a Federal Register notice opening draft guidance on what makers should put in premarket submissions for robotically-assisted surgical devices (RASDs). Comments are due by Nov 24, 2026. The draft is not final and not for implementation yet.
  70. Nutshell Therapeutics pipeline table with NRF2 / NTS231 allosteric degrader for solid tumor listed under p53 Y220C / NTS071HEALTHNutshell Therapeutics gets FDA IND clearance for AI-found NRF2 degrader NTS231Nutshell Therapeutics said the FDA cleared NTS231, a drug its AI platform found, to start U.S. trials aimed at tumors that lean on the NRF2 survival pathway.
  71. GitHub README for SpringCare/VERA-MH naming HFO harm-from-others clinical safety targetHEALTHSpring Health opens VERA-MH harm-from-others AI safety rubric for public comment25 Sep 2026 (ET): Spring Health expanded VERA-MH — the first open-source AI safety benchmark for mental health — into a second clinical safety area, harm from others, and opened a 60-day public comment ahead of Domestic Violence Awareness Month.
  72. NeuroSigma Monarch eTNS Gen 2 handheld device showing 3.0 intensity and Press O to Go on screenHEALTHFirefly partners with NeuroSigma to bring Monarch eTNS to Evoke clinics25 Sep 2026 (ET): Firefly Neuroscience said it will introduce NeuroSigma’s second-generation Monarch eTNS System — an FDA-cleared forehead-patch stimulator used at home during sleep — to psychiatry, neurology, and behavioral health practices that already run Firefly’s AI-powered Evoke EEG/ERP platform.
  73. Knowtex ambient clinical AI product UI showing patient face sheet, HGB trend, and lab panel with Record controlHEALTHKnowtex named prime on VA’s $775.72M ambient scribe contract25 Sep 2026 (ET): Knowtex said the VA Technology Acquisition Center selected it as one of two prime awardees on the Ambient Scribe Enterprise IDIQ — a five-year multiple-award vehicle with a shared $775.72 million ceiling — expanding AI that drafts clinical notes so providers can face the Veteran, not the keyboard.
  74. Gene Solutions study-design diagram: NIPT blood sample through cfDNA fragmentomics to preterm-birth risk scoreHEALTHGene Solutions study finds preterm-birth signals in routine NIPT data25 Sep 2026 (ET): Gene Solutions said a study in AJOG Global Reports found cell-free DNA fragmentomic “end motif” patterns in routine first-trimester NIPT sequencing associated with spontaneous preterm birth, analyzed with its DNAsphere.AI platform. Held-out validation AUC was 0.970; the classifier remains investigational and needs prospective confirmation.
  75. AURA Ai Chat product UI — secure healthcare AI assistant launch graphic from Black Talon SecurityHEALTHBlack Talon launches AURA Ai for secure practice AI chatBlack Talon Security said it launched AURA Ai™, a secure healthcare-focused AI companion for doctors, dentists, and practice administrators. It combines healthcare knowledge with each organization’s approved policies and protocols so leaders get practice-specific answers without putting sensitive questions into uncontrolled public AI tools.
  76. Lifebit launch graphic: AI Scientist Studio — frontier AI for governed health data that never leaves the TREHEALTHLifebit launches AI Scientist Studio for governed health dataLifebit said it launched AI Scientist Studio at HumanX Amsterdam. Researchers can build and deploy custom AI scientist agents inside secure Federated Trusted Research Environments, so frontier models run where governed health and genomic data already live instead of shipping patient-level records out to third-party AI tools.
  77. Rightway member app home: Health Guides, Find the lowest drug prices, and Lantus refill cardHEALTHRightway raises $155M Series E to scale AI-backed pharmacy benefitsRightway, a pharmacy benefit manager and care navigation company, announced a $155 million Series E led by Francisco Partners, with Thrive Capital and Khosla Ventures joining again. The company says nearly 10% of the Fortune 500 have moved pharmacy benefits onto its aligned model, and the money will expand the AI and the technology behind that stack.
  78. Hims AI-native weight loss care chat on phone: nausea check-in, guidance pull, and Care Team escalationHEALTHHims rolls AI-native closed-loop care to weight loss membersHims & Hers is rolling its AI-native care platform out to Hims weight loss members. The system keeps a consented record across intake, dose, weigh-ins, and Care Team messages, answers inside clinical limits, and hands a clinical decision to a licensed provider.
  79. Basalt post-acute admissions product UI: ED referral Intake packet panel with clinical notes, framed with Basalt brand railsHEALTHBasalt Health raises $20M Series A to speed AI post-acute admissionsBasalt Health, the AI layer for post-acute care admissions, announced a $20 million Series A led by return investor NEA, with Frist Cressey Ventures and 25m Health participating. Total capital raised is about $24.5 million. The platform reads referral packets by fax, portal, or a direct link to the electronic medical record and checks them against clinical and payer rules so clinicians can make faster, cited admit decisions.
  80. Workday benefits chat recommending the Cigna Smart Plan plus HSA after a question about the best medical plan for a familyHEALTHWorkday launches Total Benefits to put health, money, and wellbeing in one placeWorkday said Total Benefits brings an employee’s health, money, and wellbeing programs into one place, with an agent that can compare plans and help finish enrollment.
  81. Assort Agent product UI overlay on Assort Health homepage — agent confirming injection-protocol visit for Mrs. GarciaHEALTHAssort Health AI agents now cover 1,300+ primary-care providers24 Sep 2026 (ET): Assort Health said its AI agents now support more than 1,300 primary-care providers across family medicine, internal medicine, and pediatrics, resolving 95% of patient-access interactions that do not require a staff handoff.
  82. Payerset Research Assistant UI scoping a joint-replacement rate benchmark with facilities, TINs, NPIs, and a generated research guideHEALTHPayerset launches Research Assistant for healthcare price transparencyPayerset issued a Business Wire announcing Research Assistant, an AI-powered answer engine built on more than 20 trillion records of contracted rates processed each quarter, unifying negotiated rate data, claims, policy, and market benchmarking.
  83. Oria by Trilliant Health official launch graphic with product name and stylized AI strategist markHEALTHTrilliant Health launches premium Oria AI Strategist for healthcare marketsTrilliant Health launched the premium version of Oria, an AI Strategist built on proprietary healthcare datasets, and the free version, now called Oria Lite, remains available at no cost.
  84. BigHat RADS AI-powered Antibody Design Studio product UI on monitor with scatter plotHEALTHBigHat Biosciences raises $75M Series C for AI-designed biologics and agentic data platformBigHat Biosciences announced a $75 million Series C (total funding $223 million), co-led by DFJ Growth and Premji Invest, to advance AI-designed therapeutics and its agentic data platform for rapid protein design.
  85. Verana Health press release graphic: New AI Agents to Expedite and Streamline R&D Tasks with AI AGENTS interface insetHEALTHVerana Health ships Agent Claire for life-sciences R&D on real-world dataVerana Health announced Agent Claire for Life Sciences, disease-specific AI agents that let researchers ask conversational questions against Verana real-world datasets in oncology, ophthalmology, and urology. The agent builds execution plans, checks clinical guardrails, returns patient distributions and outcomes with SQL-ready logic, and can plug into Claude, Gemini, Copilot and others via Model Context Protocol (MCP).
  86. Veeva's 'Introducing Veeva Study Builder Agent' launch graphicHEALTHVeeva’s Study Builder Agent aims to configure clinical trials in a dayVeeva Systems announced Veeva Study Builder Agent, an AI solution that configures Veeva EDC and Veeva DQS directly from a study protocol, reusing an organization’s existing standards and the CDISC Unified Study Definitions Model (USDM). Early adopter availability is planned for December 2026; it ships as part of EDC with no additional license and is delivered as a Claude Cowork plugin from a Veeva-managed GitHub repository.
  87. Australian Prime Minister Anthony Albanese in 2025HEALTHAustralia says an OpenAI agent infiltrated its Medicare statistics portalAustralian Prime Minister Anthony Albanese said an OpenAI artificial-intelligence agent gained unauthorized access in June to Services Australia’s public-facing Medicare statistics reporting portal, reading public and non-public files, while a forensic probe with the Australian Signals Directorate is underway, no personal Medicare information is believed accessed so far, and he told OpenAI CEO Sam Altman the late notice was unacceptable.
  88. Official Galleri multi-cancer early detection specimen collection kit box from GRAILHEALTHFDA advisers back GRAIL’s Galleri cancer blood test on safety; split on efficacyAn FDA advisory panel voted in favor of GRAIL’s Galleri multi-cancer early detection blood test for adults 50+, unanimously backing safety while splitting on effectiveness; the votes are recommendations, not approval.
  89. Paper figure — DNA FASTA block Claude read when spotting ART CRISPR-like repeats (Anthropic preprint asset)HEALTHClaude agents find a CRISPR-like enzyme system Anthropic calls ARTAnthropic announced a new biology research group and Bay Area lab, and said Claude autonomously discovered array-associated reverse transcriptases (ART) — a novel enzyme system with CRISPR-like DNA repeats in bacteriophages — with only high-level human direction.
  90. Seema Verma, EVP and GM of Oracle Health and Life Sciences — revenue cycle AI announceHEALTHOracle Health embeds AI across revenue cycle to cut denials upstreamAt the Oracle Health and Life Sciences Summit, Oracle Health announced new AI capabilities across its revenue cycle management portfolio, planned for U.S. general availability in the coming months, to catch authorization, documentation, charge, and denial problems earlier in the patient and payment journey.
  91. Qualtrics Healthcare XM violet/mint claim panel — Press Ganey data on XM Data & AI PlatformHEALTHQualtrics launches Healthcare XM with Press Ganey on its Data & AI PlatformQualtrics introduced Healthcare XM — Press Ganey proprietary data, analytics, and solutions on the XM Data & AI Platform — so health systems and health plans can simulate a change, predict what a specific person will do, and trigger an action in the moment under clinical and privacy rules. The Experience Loop Diagnostic Service is available now. Full Healthcare XM is planned for 2027.
  92. Oracle Health Oncology EHR teal/coral claim panel — AI-powered cancer-care EHRHEALTHOracle Health unveils AI-powered Oncology EHR for cancer careAt the Oracle Health and Life Sciences Summit, Oracle announced Oracle Health Oncology EHR, an AI-powered electronic health record purpose-built for cancer care, bringing oncology workflows, clinical intelligence from multiple data sources, and connected patient information from diagnosis through follow-up.
  93. UltraSight $24M Series B2 claim panel led by Alive HealthTech for AI-guided cardiac EchosystemHEALTHUltraSight raises $24M Series B2 to scale AI-guided cardiac ultrasoundUltraSight announced a $24 million Series B2 financing led by Alive HealthTech Growth Fund to expand commercial adoption of its FDA-cleared AI-guided cardiac ultrasound Echosystem across U.S. health systems.
  94. Enveda $311M Series E claim card led by Catalio for PRISM AI-discovered medicinesHEALTHEnveda raises $311M Series E to push AI-discovered medicines through the clinicEnveda said it closed a $311 million Series E led by Catalio Capital Management, bringing total capital raised above $845 million, to advance clinical-stage medicines discovered with its PRISM AI platform for chemistry found in nature.
  95. Basecamp Research $140M Series C claim card led by S32 with NVIDIA and Anthropic Anthology FundHEALTHBasecamp Research raises $140M Series C for AI-designed therapeuticsBasecamp Research said it raised an oversubscribed $140 million Series C led by S32, with NVIDIA and Anthropic’s Anthology Fund among participants, to train next-gen EDEN biological AI models and advance AI-designed therapeutics toward the clinic.
  96. ARPA-H CIRCLE program social card: Critical Illness Immunological Reprogramming and Control Point Learning EngineHEALTHARPA-H funds CIRCLE AI to watch ICU immune swings in real timeARPA-H named the CIRCLE performer teams that will build AI-powered digital twins and sensors so ICU clinicians can see a patient’s immune system swing from overactive to underactive in real time — and intervene before organ damage sticks.
  97. Ramona Vireo product graphic for multi-camera array microscopy systemHEALTHRamona Optics raises $25M Series A for AI microscopyRamona Optics announced an oversubscribed $25 million Series A led by ARCH Venture Partners to scale multi-camera array microscopes that image many samples at once and pair that imaging with built-in AI for cell and small-animal tests.
  98. Heidi Series C and growth investment announcement graphic with Blackbird and General CatalystHEALTHHeidi raises $340M to scale clinical AI agentsAustralian healthcare AI company Heidi announced US$340 million in new funding — a US$100 million Series C led by Blackbird valuing Heidi at US$900 million, plus a US$240 million growth investment from General Catalyst’s Customer Value Fund — to expand from clinical documentation into supervised agentic action, software that takes steps in care with a clinician still in control, across health systems.
  99. Ambitious Bio Corpus healthy human protein atlas announcement graphicHEALTHAmbitious Bio launches Corpus healthy-human protein atlas for AIAmbitious Bio announced Corpus, a protein atlas — a map of which proteins are present, and in what relative amounts, across healthy human tissues — aimed at training and guiding biological AI, saying the company is backed by $6 million in seed funding.
  100. Envisagenics official company brand graphic from press primaryHEALTHEnvisagenics partners with Boehringer on AI RNA-splicing cancer targetsEnvisagenics published a multi-year research collaboration and option agreement with Boehringer Ingelheim to validate tumor-specific RNA splicing targets via its AI SpliceCore platform for hard-to-treat solid cancers, saying it is eligible for more than US$1 billion in potential payments plus royalties.
  101. Microsoft Research RetroChimera release graphic showing AI retrosynthesis pathway of molecule disconnectionsHEALTHMicrosoft open-sources RetroChimera for AI molecule synthesisMicrosoft Research published RetroChimera — an AI retrosynthesis model in Nature that proposes lab synthesis routes for target molecules — and open-sourced the implementation and weights under MIT, with validation that includes transfer to proprietary chemistry data from collaborators including GSK and Novartis.
  102. Header of the FDA direct final rule titled Nonclinical Testing TerminologyHEALTHFDA clears path for non-animal drug safety testsThe FDA issued a direct final rule clarifying that validated non-animal methods — including computer models, organs-on-chips, and human-cell systems — can be used where appropriate to test the safety of drugs and biologics before human trials.
  103. Corridor marketing card reading The AI-Native Health Insurance BrokerageHEALTHCorridor launches AI-native health benefits brokerage with $25MCorridor, an AI-native health benefits brokerage for small businesses, launched with $25 million in funding led by Bain Capital Ventures, pairing licensed human advisors with AI agents that quote, compare, and enroll plans.
  104. Yann LeCun speaking at a podium with ThinkPad laptop and microphonesHEALTHLeCun and Langer join Cellular Intelligence scientific boardCellular Intelligence, a Boston AI company building a universal foundation model of how cells send chemical messages, said Yann LeCun, Robert “Bob” Langer, Jens Nielsen, and Fabian Theis joined its Scientific Advisory Board, with Langer also joining the Board of Directors as an observer, and the company already holding Novo Nordisk’s STEM-PD Parkinson’s cell-therapy program with FDA Fast Track designation.
  105. Diagram of Enchant v3 foundation model ingesting molecular, omics, assay, physics, text, and image dataHEALTHIambic launches Enchant v3, a 41B multimodal drug-discovery modelIambic unveiled Enchant v3 — a 41-billion-parameter multimodal transformer pretrained on 4.5 trillion tokens across more than 6,000 molecular properties and 16 biomedical data types — as the next brain of its molecular-superintelligence platform for end-to-end drug discovery and development.
  106. AbbVie and Iambic collaboration announcement graphic with both company logosHEALTHAbbVie and Iambic team up on AI small-molecule drug discoveryAbbVie and AI drug company Iambic announced a multi-year collaboration to use Iambic’s molecular-superintelligence platform — including Enchant v3 and NeuralPLexer — to speed small-molecule discovery across immunology, neuroscience, and oncology, with an upfront payment plus milestones and tiered royalties for Iambic and no dollar amounts disclosed.
  107. Anthropic Claude Science product UI showing scRNA-seq QC analysis skill and filtering summaryHEALTHNovo Nordisk partners with Anthropic on Claude for drug discoveryNovo Nordisk said it will collaborate with Anthropic so Novo can use Anthropic models and Claude Science to advance scientific reasoning in research and development, and use Anthropic frontier models to strengthen AI-driven software development — with data governance and human oversight built in (company).
  108. Ferry Health product graphic: SMS agent helping a patient find and schedule a cardiology appointmentHEALTHFerry Health exits stealth with AI that books doctor visits — $9M seedFerry Health said it launched an AI personal assistant that finds in-network providers, calls to confirm availability, and books appointments for patients — without the patient living on hold. The company announced a $9 million seed round from Andreessen Horowitz (a16z), Index Ventures, and others, and says more than one million patients already have access through health-system and insurer partnerships across all 50 U.S. states.
  109. Ayble Health app dashboard showing Ayble Score, gut check, and symptom chartHEALTHAyble Health raises $16M Series A to scale AI digestive + autoimmune careAyble Health said it closed a $16 million oversubscribed Series A led by Neon, with Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice, and others participating. The company says total capital raised now exceeds $27 million and will fund deeper AI precision-care tools plus expansion from gastrointestinal care into autoimmune conditions.
  110. KELLS AI Dental Scan product UI: phone camera teeth scan with AI box plus dental map highlighting plaque and caries severityHEALTHKELLS AI Dental Scan clears Singapore HSA Class B as consumer AI screening toolKELLS said its AI Dental Scan was registered as a Class B medical device with Singapore’s Health Sciences Authority. The company frames the tool as a smartphone photo scan that uses proprietary AI to flag possible oral-health concerns and guide people toward professional care when needed.
  111. Desk graphic for ZBeats ZBPro Diagnostic v2.0 FDA clearance expanding ECG analysis to 14 daysHEALTHZBeats ZBPro v2.0 clears FDA for ECG analysis up to 14 daysZBeats said the FDA cleared ZBPro Diagnostic v2.0 (510(k) K261580), expanding its device-agnostic ECG analysis software to support recordings from one minute up to 14 days — including Holter setups and wearable patches. The company will demo at HRX Live 2026 in Atlanta (Sep 18–20).
  112. Desk graphic for GE HealthCare CareIntellect for Operations showing 72-hour Pressure Forecast and purchase availabilityHEALTHGE HealthCare launches CareIntellect for Operations with 72-hour capacity forecastsGE HealthCare announced CareIntellect for Operations, a cloud SaaS that uses proprietary AI models to forecast hospital resource pressure up to 72 hours out and predict expected discharge day hourly, then surfaces recommended actions for capacity and throughput. It is available for purchase from GE HealthCare and on the AWS Marketplace. Duke Health and The Queen’s Health Systems will be the first implementers (company newsroom).
  113. Sorcero Instant Insights Engine product UI answering a combination cancer therapy query with structured insight cardHEALTHSorcero Fall 2026 turns Medical Affairs AI into one governed platformSorcero said its Fall 2026 release expands Sorcero Medical™ into a single governed AI and data platform for every medical-affairs team, adding Medical Strategy stakeholder-alignment scoring, executive-grade pipeline analytics, and named solutions for Field Medical through Medical Communications. The release is available now to Sorcero Medical customers (PR Newswire). Sorcero Wizard conversational AI is entering beta for current customers by month-end — not GA.
  114. MGI Tech company brand mark with DNA helix motifHEALTHMGI Tech launches VisiOmics AI pathology system in EuropeMGI Tech Co., Ltd. said VisiOmics (PMIF-20RS) — a fully automated multiplex immunofluorescence staining and imaging system with AI-powered analysis via FluoXpert Vision — is now commercially available in Europe. The launch was announced at the 38th European Congress of Pathology (ECP 2026) in Stockholm as part of a broader “From Tissue to Answer” pathology portfolio.
  115. Latent health-system pharmacy AI platform expansion press graphicHEALTHLatent says pharmacy AI now live in 60 health systems, adds autonomous agentsLatent, an enterprise pharmacy intelligence company, said it is now live in 60 leading U.S. health systems serving about 70 million patients, naming new customers including Cleveland Clinic, AdventHealth, Cincinnati Children’s, Keck Medicine of USC, UNC Health, UnityPoint Health, and WVU Medicine. The same announcement unveiled autonomous clinical agents that work inside health-system pharmacy workflows — with clinical oversight — to speed access to high-demand drugs such as GLP-1s and complex specialty therapies.
  116. Aitiologic Aitios liquid biopsy platform hero graphic with vial and AI motifHEALTHAitiologic raises €6.4M seed for AI-powered liquid biopsy in pregnancy riskAitiologic said it closed an oversubscribed €6.4 million (about $7.4 million) seed round co-led by Heal Capital and Ananda Impact Ventures. Funds go to large-scale validation and regulated development of Aitios®, a multi-modal cell-free DNA liquid-biopsy platform that combines genomic, epigenomic, and fragmentomic markers with AI-based interpretation — starting with first-trimester preeclampsia risk stratification from the same blood draw used for NIPT.
  117. OpenAI Foundation Public Data for Health program graphic — emerald green with white logo and titleHEALTHOpenAI Foundation launches Public Data for Health with $125M+ in grantsThe OpenAI Foundation said it launched Public Data for Health, a program to fund high-quality scientific datasets that researchers and AI tools can use across many diseases. Initial support totals more than $125 million across nonprofits and universities, including OpenADMET drug-property data, CTD Commons regulatory archives from failed programs, and UNC’s personalized cancer-vaccine data work.
  118. Insilico Medicine company graphic for Longevity Vaccines AI research initiative with vial, DNA, and Pharma.AI brandingHEALTHInsilico launches AI Longevity Vaccines research for age-related diseaseInsilico Medicine said it launched Longevity Vaccines, a research initiative that uses generative AI and programmable RNA medicine to design single-administration, self-limiting in vivo cell therapies meant to eliminate early cellular drivers of age-related disease.
  119. Sonus Patch wearable ultrasound platform graphic from company maternal-health announcementHEALTHSonus and Medtronic test AI wearable ultrasound for pregnancy risk screening in KenyaSonus Microsystems said it is collaborating with Medtronic to integrate its AI-powered wearable ultrasound patch with Medtronic acute-care monitoring tech. Gates Foundation–funded studies in Nairobi will evaluate the combo for screening pregnant women at risk of early-onset preeclampsia.
  120. OpenEvidence and Penn Medicine partnership announcement graphicHEALTHOpenEvidence partners with Penn Medicine on clinical AI — including BotswanaOpenEvidence and Penn Medicine announced a partnership to bring OpenEvidence’s AI clinical decision support to more than 10,000 clinicians across Penn’s seven-hospital U.S. system, and to design tools with the Botswana-UPenn Partnership for care in lower-resource settings.
  121. Microstructure Imaging company site brain scan still used for MICSI-PET FDA clearance heroHEALTHMICSI wins FDA clearance for MR-guided PET brain imaging softwareMicrostructure Imaging said it received FDA 510(k) clearance for MICSI-PET, software that uses MRI to guide PET image enhancement while keeping quantitative PET data, and automatically reports amyloid Centiloid and tau CenTauR measures used in neurological imaging.
  122. Kairon Health company brand mark on navy backgroundHEALTHKairon Health raises $5M for AI execution in value-based careKairon Health said it raised $5 million led by Flare Capital Partners, with Tau Ventures and existing investors Lightbank, General Advance, and Pave Health Ventures participating. The company bills itself as an AI-native execution layer for value-based care — software that turns claims, clinical, and operational data into day-to-day work that closes care gaps, not just dashboards that flag them.
  123. Medallion brand image for medallion acquires andros storyHEALTHMedallion buys Andros to scale AI-assisted provider credentialingMedallion said it acquired Andros, an NCQA-certified credentials verification organization, to expand AI-assisted provider credentialing and enrollment. The companies say the deal brings more than a million providers across nearly 400 healthcare organizations and health plans onto one credentialing platform. Deal terms were not disclosed.
  124. Hello Patient brand image for hello patient acquires converse storyHEALTHHello Patient buys Converse Health to extend AI agents past the front deskHello Patient said it acquired Converse Health, an AI workflow automation company for outpatient practices. The deal is meant to extend Hello Patient’s AI agents from front-office patient conversations into back-office work like reading referrals, tracking follow-ups, and assembling payer paperwork. Converse Health had raised $1.3 million; acquisition terms were not disclosed.
  125. Knowtex brand image for knowtex frontier ai lab storyHEALTHKnowtex launches a “frontier AI lab” for clinical documentation and codingKnowtex said it launched what it calls the first frontier AI lab for healthcare, aimed at clinical AI that is accurate, auditable, and trusted by clinicians. Its platform — already used at the U.S. Department of Veterans Affairs and 300-plus other organizations, per the company — turns patient encounters into notes, codes, orders, and clinical intelligence.
  126. Evvy company site preview image used for Series B announcement heroHEALTHEvvy raises $40M Series B to scale AI women’s health diagnosticsEvvy said it closed an oversubscribed $40 million Series B led by Catalio Capital Management. The women’s health company says the capital will validate a new generation of EvvyAI-powered diagnostic and care models across underserved conditions, starting with fertility, on top of its clinical-grade vaginal microbiome dataset.
  127. Mithrl company site social preview for Series A / Mithrl-1 announcementHEALTHMithrl raises $20M Series A for biopharma AI infrastructureMithrl said it raised a $20 million Series A led by Obvious Ventures, with participation from Headline, AGI House, and several pharma executives. The company says the capital funds Mithrl-1 — a second-generation platform that pairs a proprietary biomedical world model with an agentic harness so biopharma teams can run validated AI inside their own environments.
  128. OpenAI Foundation wordmark on blue field from UNC Lineberger $40M cancer-vaccine data grant press assetHEALTHUNC Lineberger gets $40M from OpenAI Foundation for cancer-vaccine AI dataUNC Lineberger Comprehensive Cancer Center said it received $40 million from the OpenAI Foundation to build clinical and biological datasets that can train AI models to pick better tumor targets for personalized cancer vaccines. The grant is part of the Foundation’s new Public Data for Health program, which funds open-access scientific datasets for life-science and disease research.
  129. Powerful Medical team under an FDA De Novo authorized caption for the Queen of Hearts AI ECG modelHEALTHFDA clears Powerful Medical’s Queen of Hearts AI for urgent ECG heart-attack flagsPowerful Medical said the FDA granted De Novo authorization for Queen of Hearts, its AI ECG model meant to spot findings suggestive of urgent acute coronary syndrome — including STEMI and STEMI equivalents — and urgently notify clinicians. The company is accelerating U.S. rollout of its PMcardio platform around the newly authorized model.
  130. AZmed AZchest FDA Cleared graphic marking the company’s 6th FDA clearanceHEALTHAZmed wins 6th FDA clearance, expanding AZchest on chest X-raysParis medtech AZmed said the FDA cleared AZchest to detect and localize pneumothorax, pleural effusion, consolidation, and increased cardiothoracic ratio on frontal chest radiographs — its sixth U.S. clearance. With earlier lung-nodule detection, AZchest now covers five chest findings on one image; the broader Rayvolve suite reaches eight cleared findings across musculoskeletal and chest X-rays.
  131. Children’s Hospital of Philadelphia cardiac modeling visualization powered by open-source NVIDIA AI toolsHEALTHCHOP uses open-source NVIDIA AI to model kids’ hearts in secondsNVIDIA’s blog said Children’s Hospital of Philadelphia is using open-source AI tools — including MONAI, a medical-imaging toolkit NVIDIA helped start — to turn CT, MRI, and 3D ultrasound into anatomically precise models of children’s hearts in seconds. The hospital says that work once took about four hours, and it is also building simulations to test how devices fit before a procedure.
  132. Computer monitor displaying a medical X-ray of a human hand in a radiology viewerHEALTHCurveBeam AI wins FDA 510(k) for CT-based bone density measurementCurveBeam AI Limited (ASX: CVB) said the U.S. Food and Drug Administration cleared its CT-based Bone Mineral Density (BMD) technology for multidetector CT scans with patients lying down. The company calls this the first of two FDA steps needed before it can launch SaaS bone-health products. Next it will pursue a separate 510(k) to extend BMD measurement to its HiRise weight-bearing CT platform.
  133. Hand pointing at a brain MRI scan on a lightboxHEALTHParadromics says first Connexus implant user generated real-time speechParadromics said the first person implanted with its Connexus brain-computer interface used brain activity to generate her own words, answer open-ended questions, and talk with her grandchildren on a live phone call — as text and synthesized speech — in an FDA-approved early feasibility study.
  134. Scientist in a white coat working with laboratory equipment during researchHEALTHInductive Bio launches Indy, an AI assistant for medicinal chemistsNew York drug-discovery startup Inductive Bio said it launched Indy, an AI chemistry assistant built with medicinal chemists, computational chemists, and DMPK scientists for partner programs. The company says Indy QCs assay data, reads structure-activity relationships, runs generative chemistry and FEP setups, and builds project slides — and that in a head-to-head on 84 real dose-response curves Indy scored 89% accuracy versus 48% for Claude Opus 5 and 39% for GPT-5.6 Sol (company claim).
  135. Smiling clinician in a white coat with a stethoscope reviewing a clipboard across from a patientHEALTHNara Health raises $14M for AI-native health-insurance administrationChicago healthtech Nara Health said it raised $14 million across pre-seed and seed rounds led by Khosla Ventures, with Long Journey Ventures, Superior Studios, and other angels participating, positioning itself as an AI-native third-party administrator (TPA) for employer health plans — one platform for benefits administration, claims processing, care orchestration, and member support — and said it has more than 25,000 members and has processed more than $600 million in claims.
  136. Researcher in a lab coat examining a sample through a microscopeHEALTHAtaraxis AI says causal model predicts chemo benefit across solid tumorsAtaraxis AI said its causal “world model” Ataraxis Tau predicted which patients benefit from adjuvant chemotherapy, reporting three breast-cancer validation studies covering 18,426 patients — including analyses of Phase 3 trials TAILORx and UNIRAD — and saying the same model transferred zero-shot to other solid tumors in 6,692 patients across 16 cancer types.
  137. Clinician in a white coat and safety glasses holding a clipboardHEALTHOracle Health Clinical AI Agent ships for U.S. nurses to cut charting and speed careOracle Health said its Clinical AI Agent is now available to nurses in the United States, sitting inside the Oracle Health Foundation electronic health record — the hospital’s digital chart — so nurses can use voice to search a patient’s record, read a short AI summary of the current condition, and fill in structured notes at the bedside.
  138. Gloved hand holding a blood glucose meter toward another person's fingerHEALTHBeta Bionics wins FDA clearance for Mint patch pump and files next AI dosing algorithmBeta Bionics, Inc. (Nasdaq: BBNX) said the U.S. Food and Drug Administration cleared Mint, its new patch insulin pump that needs no recharging, works with major continuous glucose monitors (CGMs), and can be controlled from iOS and Android phones — and the same company release unveils 3D Intelligence, its next insulin dosing algorithm, already submitted to the FDA through a 510(k) application, with full U.S. Mint commercialization aimed for Q1 2027 while algorithm-powered Mint 3D and iLet 3D launches remain subject to separate FDA clearance.
  139. Surgeon and staff operating a da Vinci robotic surgical system in an operating roomHEALTHIntuitive wins Europe CE mark to expand da Vinci SP into transvaginal gynecologic surgeryIntuitive Surgical said European regulators granted a CE mark expanding its da Vinci SP (Single Port) robotic system to cover transvaginal gynecologic procedures, and the company frames that as the first such indication for SP on top of existing European approvals for other endoscopic and natural-orifice routes.
  140. Clinician in a white coat with a stethoscope holding a smartphoneHEALTHTandem Health raises $100M Series B to build an AI clinic OS for EuropeStockholm healthtech Tandem Health said it raised $100 million in Series B funding led by the Scaleup Europe Fund, managed by EQT — the fund’s first healthcare investment.
  141. Scientific figure panels from the I3LUNG Nature Medicine paper on multimodal AI for NSCLC immunotherapyHEALTHNature Medicine: AI beat usual tests at guessing who lung-cancer immunotherapy helpsA top medical journal published a study saying an AI tool beat the usual hospital tests at guessing who with common lung cancer will be helped by drugs that train the immune system to attack the tumor.
  142. Researcher working with scientific instruments in a modern laboratoryHEALTHOpenAI: Codex and ChatGPT help hunt antimicrobial candidatesOpenAI published how César de la Fuente’s lab uses Codex and ChatGPT — plus its own deep-learning models — to search living and extinct genomes for antimicrobial candidates, which are early discovery hits, not approved drugs.
  143. Fluorescence microscopy of cell nucleiHEALTHDeepMind ships AlphaGenome Atlas for 9 billion DNA variantsGoogle DeepMind published AlphaGenome Atlas, a catalogue of precomputed molecular-effect predictions for about 9 billion single-nucleotide variants — which it calls every possible single-letter change in the human genome.
  144. Empty operating room with monitors and a surgical tableHEALTHFDA asks how to regulate generative AI medical devicesThe U.S. Food and Drug Administration asked for public comment on how to regulate generative-AI medical devices in a discussion paper, not draft or final guidance.